http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2731813-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b3db7dd56b56cc6d94d0e0cccc38322 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-592 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-062 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-42 |
| filingDate | 2014-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9997c0b3ec3263b94c94b8d0238030f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_395d46825e4b458e884e0b2c9f4a057e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99d5faa3e52dea31b3e921d756f79394 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c585600e542eee35909009ed200371e4 |
| publicationDate | 2019-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2731813-T3 |
| titleOfInvention | Cosmetic or dermatological composition comprising a merocyanine and an oil phase comprising at least one specific amide compound |
| abstract | Cosmetic or dermatological composition comprising, in a physiologically acceptable support: a) at least one merocyanine corresponding to one of the following formulas (1) or (2), or one of its forms of geometric isomers E / E or E / Z : ** Formula ** in which: R1 and R2 are, independently of each other, hydrogen; a C1-C22 alkyl group, a C2-C22 alkenyl group or a C2-C22 alkynyl group, it being possible for these groups to be substituted with at least one hydroxyl group or to be interrupted with at least one -O-; or alternatively, R1 and R2 form, together with the connecting nitrogen atom, a - (CH2) n- ring which may be optionally interrupted by -O- or -NH-; R3 is a group - (C = O) OR6 or a group - (CO) NHR6; R6 is a C1-C22 alkyl group, a C2-C22 alkenyl group, a C2-C22 alkynyl group, a C3-C22 cycloalkyl group or a C3-C22 cycloalkenyl group, it being possible for said groups to be substituted with one or more OH groups; R4 and R5 are hydrogens; or R4 and R5 form a ring - (CH2) n- which may be substituted with a C1-C4 alkyl group and / or interrupted with one or more -O- or -NH-; n is a number between 2 and 7; R7 and R8 are, independently of each other, hydrogen; a C1-C22 alkyl group, a C2-C22 alkenyl group or a C2-C22 alkynyl group, it being possible for said groups to be interrupted with one or more O and / or substituted with one or more OH groups; a C3-C22 cycloalkyl group or a C3-C22 cycloalkenyl group, said groups being possible to be interrupted by one or more -O-; or alternatively, R7 and R8 form, together with the nitrogen that connects them, a ring - (CH2) n- that can be interrupted by one or more -O-; R9 and R10 are hydrogen; or R9 and R10 form a ring - (CH2) n- which can be substituted with a C1-C4 alkyl and / or interrupted with a -O- or -NH-; A is -O- or -NH; R11 is a C1-C22 alkyl group; a C2-C22 alkenyl group; a C2-C22 alkynyl group; a C3-C22 cycloalkyl group or a C3-C22 cycloalkenyl group, it being possible for said groups to be interrupted with one or more O; or a C1-C22 alkyl group or a C2-C22 alkenyl group which is substituted with a C3-C22 cycloalkyl group or a C3-C22 cycloalkenyl group, it being possible that said C3-C22 cycloalkyl group or cycloalkenyl group of C3-C22 is interrupted by one or more -O-; with the proviso that: (I) at least one of the groups R1, R2 or R6 is substituted with a hydroxyl; (II) if one of the groups R1 represents a hydroxyethyl, R2 does not represent a hydrogen, a methyl or an ethyl, or a hydroxyethyl; and if R1 represents hydrogen, R2 is not 1-hydroxy-3-methyl-2-butyl; (III) if R6 is substituted with one or more OH groups, one of R1 and R2 is a C4-C22 alkyl group; or alternatively, R1 and R2 form, together with the nitrogen to which they are attached, a piperidyl or morpholinyl radical; (IV) at least one among the radicals R7, R8 and R11 is interrupted by one or more -O-; and b) at least one oily phase comprising at least one amide compound of formula (I) below: ** Formula ** wherein R 'is a linear or branched, saturated or unsaturated C4-C22 alkyl radical, and R "and R" ', which may be identical or different, are linear or branched C2-C10 alkyl radicals, optionally substituted with a hydroxyl group; R 'and R "' can form, with the nitrogen atom and the carbonyl group, a caprolactam ring; R" and R "'can form, with the nitrogen atom to which they are attached, a heterocycle comprising from 4 to 6 carbon atoms, which can contain one oxygen atom. |
| priorityDate | 2013-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 374.